Multiple Sclerosis Medication Review Articles|omicsgroup|Journal Of Multiple Sclerosis

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Webinars & Conferences

Global Neuroscience and Neurology Conference

Prague, Czech Republic

Annual Summit on Neurological Disorders & Stroke

Webinar, Webinar

Multiple Sclerosis Medication Review Articles

Medications used to treat multiple sclerosis include modifying therapies to manage the symptoms and heal the exacerbations. Multiple sclerosis medications reduce and help to manage the common symptoms including bowel dysfunction, depression, sexual problems, spasticity, tremors etc. The common medications used involves methylprednisolone, prednisone etc. But Corticosteroids are not considered as an effective medication to benefit the disease. Some of the effective medications used are glatiramer acetate, fingolimod, peginterferon, beta-1ainterferon, beta-1 adi methyl fumarate, natalizumab etc. Review articles are the summary of current state of understanding on a particular research topic. They analyze or discuss research previously published by scientist and academicians rather than reporting novel research results. Review article comes in the form of systematic reviews and literature reviews and are a form of secondary literature. Systematic reviews determine an objective list of criteria, and find all previously published original research papers that meet the criteria. They then compare the results presented in these papers. Literature reviews, by contrast, provide a summary of what the authors believe are the best and most relevant prior publications.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on February, 2021